Biopharmaceutical start-up Ilypsa used IntraLinks throughout its corporate lifecycle and drug development process. The company saved precious time and resources while sharing information with partners throughout the world, expanding its reach, raising funds and ultimately facilitating a successful sale of the company.

As with any biotech start-up, conducting research requires capital – and that means raising funds. Ilypsa needed a cost-effective, flexible solution to coordinate financing and facilitate due diligence. Ilypsa selected IntraLinks Exchanges as a repository to protect its information based on the company’s advanced security features and track record.

To read the complete case study please click here.